DGAP-News: Raptor Pharmaceutical Corp. to Present at Cystinosis Research Foundation Day of Hope Family Conference
Raptor Pharmaceutical Corp.
12.04.2012 12:30
—————————————————————————
NOVATO, Calif., 2012-04-12 12:30 CEST (GLOBE NEWSWIRE) —
Raptor Pharmaceutical Corp. (–Raptor– or the –Company–) (Nasdaq:RPTP) today
announced that Ted Daley, President, will present an update on its
investigational drug candidate, Cysteamine Bitartrate Delayed-Release Capsules
(RP103), for the potential treatment of nephropathic cystinosis at the
Cystinosis Research F
